期刊文献+

孕妇血清妊娠相关蛋白A检测及妊娠结局分析 被引量:1

Determination of serum pregnancy associated plasma protein A(PAPP-A) in pregnancy women and analysis outcome of the pregnancy
下载PDF
导出
摘要 目的探讨妊娠相关蛋白A(PAPP-A)作为血清标记物在孕早期产前筛查中应用的价值。方法用酶联免疫吸附法(ELISA)测定孕9~14周孕妇血清中PAPP-A浓度,检测结果低于正常下限值的孕妇视为胎儿染色体异常的高危人群,并对其进一步行羊水染色体检查及B超检查,每例受检的孕妇随访追踪到胎儿出生。结果共检测1380例9~14周单胎妊娠孕妇,筛查出PAPP-A低值的高危孕妇107例,确诊染色体异常3例(2例21-三体,1例47,XXY),高危组不良妊娠结局9例,筛查高危组与筛查低风险组不良妊娠结局比较有显著差异(χ2=39.36,P<0.01)。结论PAPP-A可作为孕早期染色体三体异常筛查的一个指标,对于PAPP-A低值的孕妇提示有不良妊娠结局的可能。 Objective:To investigate the value of determination of the serum marker PAPP-A for screening testing early pregnancy. Methods:Serum PAPP-A concentration were determined with ELISA in early (9~14 weeks) gestation, Pregnant women were assumed in high risk group of fetal chromosome abnormal if their PAPP-A concentration were below lower limit. Chromosome examination of amniotic fluid and B-ultrasonography were further performed, follow-up study was continued until fetalbirth. Results:Altogether 1380 pregnancy women were tested,107 of which were regarded as of high risk group.Among high risk once, 3 cases with fetal chromosome abnormality (two cases trisomy 21 and one case 47,XXY)were identified,outcome of the Pregnancy was terminated unfavorably in 6 womenof them, the unfavorable rate was significantly higher than that in the non-high risk group(χ2=39.36,P<0.01).Conclusion: PAPP-Aisa very usefulmarker for serum screening of chromosome trisomy abnormality in early pregnancy,and depressed levels also suggest a possible unfavorable outcome of the Pregnancy.
出处 《中国优生与遗传杂志》 2005年第6期47-48,共2页 Chinese Journal of Birth Health & Heredity
关键词 妊娠相关蛋白A 酶联免疫法 产前筛查 染色体异常 PAPP-A ELISA Antenatal screening Chromosome abnormality
  • 相关文献

参考文献9

  • 1WaldNJ,Hachshaw A, Stone R,et al. Serum PAPP-A levels are depressed in women with fetal Down's syndrome in early pregnancy[J]. Prenat Diagn,1993,13:633~636.
  • 2Wald NJ,Ggorge L,Smith D,et al.Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy[J]. Brish Journal of Obstertrics and Gynaecology,1996,103:407.
  • 3Roberts D,Walkinshaw SA, Mccormack MJ,et al. Prenatal detection of trisomy 21 :combined experience of two British hospitals [J].Prenat Diagn, 2000,20:17~22.
  • 4Yaron Y, Ochshorn Y, Tsabari S, Shira AB.First-trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A can detect triploidy and determine the parental origin. [J]. Obstet Gynecol. 2004 Jul,104(1):30-6.
  • 5龚颖萍,王华,方超英,金明华,黄定梅,雷骁.妊娠相关蛋白A测定筛查胎儿先天缺陷的临床应用[J].医学临床研究,2003,20(3):170-171. 被引量:7
  • 6吴忠琴,杨雪,郭敬芝,梁雪雯,孙袁.孕妇血清妊娠相关蛋白A检测及意义[J].放射免疫学杂志,2004,17(1):76-77. 被引量:7
  • 7秦桂萍,刘惠喜.PAPP-A及其在妇产科临床的应用价值[J].国外医学(妇幼保健分册),2000,11(1):31-35. 被引量:28
  • 8鲍培忠.多种血清标记物在产前筛查中作用的综合评价[J].国外医学(计划生育分册),1999,18(2):74-78. 被引量:56
  • 9Bersinger NA, Leporrier N, Herrou M, Leymarie P. Maternal serum pregnancy-associated plasma protein A (PAPP-A) but not pregnancy-specific beta1-glycoprotein (SP1) is a useful second-trimester marker for fetal trisomy 18. [J].Prenat Diagn, 1999 Jun,19(6):537-41.

二级参考文献12

  • 1Spencer K,Noble P,Sni j ders RJ,et al. Prenatal Diagnosis . 1997
  • 2Biasio DP,siccardi M,Volpe G,et al. Prenatal Diagnosis . 1999
  • 3Casals E,Fortuny A,Grudzinsksa JG,et al. Prenatal Diagnosis . 1996
  • 4Kristensen T,Oxvi g C,Sand O,et al. Biochemistry . 1994
  • 5Lawrence JB,Oxvi gc,Overgaard MT,et al. Proceedings of the National Academy of Sciences of the United States of America . 1999
  • 6Forest JC,Mass J,Mout quin JM. Clinical Biochemistry . 1997
  • 7Jannianx E,Btrsinger NA,Gulbis B,et al. Human Reproduction . 1999
  • 8Degraaf IM,Bezouw SM,Jokobs ME,et al.Prenatal Diagn, 1999;19: 175~177 S[13] Mantingh A[].Prenatal Diagnosis.1998
  • 9李敏,王庆一.先兆流产孕妇妊娠相关血浆蛋白A含量测定及意义[J].广州医药,1999,30(5):42-42. 被引量:9
  • 10李文典,岳亚飞.唐氏胎儿妊娠筛查血清标志物妊娠相关血浆蛋白A研究进展[J].国外医学(妇幼保健分册),2000,11(1):13-16. 被引量:11

共引文献91

同被引文献19

  • 1邓亚丽,李晓玲.血清孕酮测定对异位妊娠诊断与监测的价值[J].中国实用妇科与产科杂志,2005,21(2):106-106. 被引量:33
  • 2黄仲英,李尚为,谭宗建,马黔红,林卫.血β-hCG对体外受精-胚胎移植后妊娠早期诊断的预测价值[J].华西医学,2005,20(3):492-493. 被引量:11
  • 3Lohstroh PN,Overstreet JW,Stewart DR,et al.Secretion and excretion of human chorionic gonadotropin during early pregnancyFertil Steril,2005,83(4):1000-1011.
  • 4Gillian-Homan BN,Susan-Brown RN,John-Moran MBBS,et al.Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies.Fertil Steril,2000,73(2):270-274.
  • 5Papageorgiou TC,Leondires MP,Miller BT,et al.Human chorionic gonadotropin levels after blastocyst transfer are highly predictive of pregnancy outcome.Fertil Steril,2001,76(5):981-987.
  • 6Ransom A,Garcia AJ,Bohrer M,et al.Serum progesterone as a predictor of methotrexate success in treatment of ectopic pregnancy.Obstet Gynecol,1994,83(12):1033-1037.
  • 7Perkins SL,AL-Ramahi M,Claman P.Comparison of serum progesterone as an indicator of pregnancy nonviability in spontaneously pregnant emergency room and infertility clinic patient populations.Fertil Steril,2000,73(3):499-504.
  • 8Van Thillo G,Inza P,Basconi V,et al.Predictability of pregnancy viability after assisted reproductive techniques(ART)cycles by CA-125 and progesterone serum levels on the day of β-hCG testing.Fertil Steril,2006,86 Suppl 3:149.
  • 9Young E Jr,Domenech L,Ponte L,et al.Pregnancy outcome after ART may be predicted by serum progesterone levels on the day of β-hCG testing.Fertil Steril,2006,86(3):346.
  • 10Ellenbogen A,Gidoni Y,Michael M,et al.Mid-luteal serum progesterone and estradiol levels as predictors of pregnancy in IVFET cycles:may increasing the dosage of progesterone supplementation improve the outcome.Fertil Steril.2004,82 Suppl 2:205-206.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部